Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

And here’s what else you need to know to Start Your Week Smart . Your day is busy. 5 Things is your one-stop shop for the ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

Honda and Nissan begin merger talks with a plan for the combination to be completed in 2026, Qualcomm scores a victory in its ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...

Zepbound, from drugmaker Eli Lilly, is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood ...

Hopes for a 'Santa Claus' rally looked to be alive again on Monday as S&P 500 futures also were climbing and Nasdaq 100 futures gained in premarket trading.

In another milestone, Eli Lilly's weight-loss medication, Zepbound, received FDA approval, marking it as the first drug to specifically tackle moderate to severe obstructive sleep apnea in obese ...

The Japanese c ...